Overview
Douglas Wentzel focuses his practice on patent and trade secret litigation. Doug has successfully represented clients in district courts across the country and before the International Trade Commission (ITC) and Patent Trial and Appeal Board (PTAB). His cases have covered a broad spectrum of technologies, including wearable health devices, minimally invasive heart repair devices, respiratory therapy products, automotive shock absorbers, microdermabrasion systems, and more. Additionally, Doug has experience litigating design patents.
Doug is also a registered patent attorney and has experience drafting and prosecuting patent applications through allowance before the U.S. Patent and Trademark Office.
Doug holds a leadership position in the Young Lawyers Division of the Federal Bar Association’s Orange County Chapter. He has also provided pro bono legal services, including by representing a veteran in an appeal before the U.S. Court of Appeals for Veterans Claims.
Doug received his B.S. in Civil Engineering from Drexel University, where he graduated summa cum laude and collaborated in designing an 18-story proposed addition to a university dormitory. He received his J.D. with honors from the University of Pennsylvania Law School, where he founded a program to help engineering students incorporate intellectual property considerations into their hypothetical start-up businesses.
Education
- University of Pennsylvania Law School (PENN) (J.D., 2016), cum laude, Associate Editor, The University of Pennsylvania Law School Journal of Business Law
- Drexel University (B.S. Civil (Structural) Engineering, 2013), summa cum laude, Graduation with Distinction from Honors College
Recognition
Awards & Honors
- Named a 2023 Rising Star in IP by Managing IP
Affilliations
- American Bar Association
- Association of Business Trial Lawyers – Orange County
- Federal Bar Association – Central District of California”
- Orange County Bar Association
News & Insights
Articles
Co-author, “35 U.S.C. § 325(d) Petition Practice in Ex Parte Reexaminations,” Reuters Westlaw, October 2024.
Co-author, “Tips for Patent Prosecutors from Litigators: Enhancing Litigation Outcomes,” IP Watchdog, August 2024.
Journal Articles
- Stays Pending Inter Partes Review: Not in the Eastern District of Texas, 98 J. Pat. & Trademark Off. Soc’y 120 (2016)
- Uber & Alice: Could One Patent Really Take Down this Ridesharing Giant?, 98 J. Pat. & Trademark Off. Soc’y 86 (2016)
Editor and Contributor, KnobbeMedical.com Blog
- AI & the FDA
- Developments in Patent Disputes Between Apple and Alivecor
- Apple Watch Found to Infringe AliveCor ECG Patents
- Medical device innovations and IP: A strategy is everything.
- BioNTech to Ship Modular mRNA Vaccine Factory to Rwanda
- AI and Cancer Diagnostics
- Federal Circuit Reverses District Court’s Decision Based on On-Sale Bar (Junker v. Medical Components, Inc.)
- FDA Seeks $7.2 Billion Budget for 2024
- FDA: Approval for Novel Medical Devices Remains a High Priority, Despite COVID-19
- FDA Breakthrough Device Designation for Biology-Guided Radiotherapy (‘BgRT’) Device
- Alpha Tau Receives FDA Breakthrough Device Designation for Alpha DaRT Treatment of GBM
- Medical Device Trade Secret Not Publicly Disclosed via Patenting, Displaying, and Selling Covered Product, 7th Cir. Affirms
- FDA Taking Steps to Prevent Future Medical Device Shortages
- Boston Scientific To Acquire Blood Clot Removal Tech Company Devoro Medical
- Stryker to Acquire Surgical Smoke Evacuator Company SafeAir
- Materialise Receives First-Ever 510(k) Clearance for Anatomical Model 3D Printing Software
- FDA Issues Final Guidance on Software as a Medical Device
- Testing of Jenex TherOZap™ Device Set to Begin
Editor and Contributor, Knobbe Martens Litigation Blog
-
An Expert Witness Need Not Have Been a Posita at the Time of the Invention
-
Skinny Labeling May Not Be Enough to Avoid Induced Infringement Allegations
-
Unclean Hands and Inequitable Conduct: Dishonesty Is Not the Best Policy
-
Claimed Ranges Overlapping the Prior Art Can Lead To Short Patent Shelf-Life
-
Exhibit Combustion: Disavowing Contradictory Statements Contained in Complaint Exhibits
-
The Patent Ineligibility of Digital Imaging Processing Method Claims
-
Incorporation by Reference: Patent Portfolio Builder or Destroyer?
-
Result-Oriented Claims Based on Natural Laws Held Invalid Under § 101